{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:26:16Z","timestamp":1785878776273,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,3,16]],"date-time":"2014-03-16T00:00:00Z","timestamp":1394928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00774-014-0580-z","type":"journal-article","created":{"date-parts":[[2014,3,18]],"date-time":"2014-03-18T05:40:41Z","timestamp":1395121241000},"page":"161-172","source":"Crossref","is-referenced-by-count":13,"title":["The effects of bazedoxifene in the ovariectomized aged cynomolgus monkey"],"prefix":"10.1007","volume":"33","author":[{"given":"Susan Y.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelin","family":"Jolette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Chouinard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry S.","family":"Komm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,16]]},"reference":[{"key":"580_CR1","unstructured":"Fast Facts on Osteoporosis. National Osteoporosis Foundation. http:\/\/www.nof.org\/node\/40 . Accessed 28 Feb 2014"},{"key":"580_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res 22:465\u2013475","journal-title":"J Bone Miner Res"},{"key":"580_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.blo.0000200248.34876.fe","volume":"443","author":"OS Atik","year":"2006","unstructured":"Atik OS, Gunal I, Korkusuz F (2006) Burden of osteoporosis. Clin Orthop Relat Res 443:19\u201324","journal-title":"Clin Orthop Relat Res"},{"key":"580_CR4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pickard L, Kennedy CC, Prior JC, Olszynski WP, Davison KS, Goltzman D, Thabane L, Gafni A, Papadimitropoulos EA, Brown JP, Josse RG, Hanley DA, Adachi JD (2009) Relation between fractures and mortality: results from the Canadian Multicentre Osteoporosis Study. CMAJ 181:265\u2013271","journal-title":"CMAJ"},{"key":"580_CR5","first-page":"1551","volume":"34","author":"F Salaffi","year":"2007","unstructured":"Salaffi F, Cimmino MA, Malavolta N, Carotti M, Di ML, Scendoni P, Grassi W (2007) The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol 34:1551\u20131560","journal-title":"J Rheumatol"},{"key":"580_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/gme.0b013e3181c617e6","volume":"17","author":"Management of osteoporosis in postmenopausal women","year":"2010","unstructured":"Management of osteoporosis in postmenopausal women (2010) 2010 position statement of The North American Menopause Society. Menopause 17:25\u201354","journal-title":"Menopause"},{"key":"580_CR7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI27987","volume":"116","author":"BJ Deroo","year":"2006","unstructured":"Deroo BJ, Korach KS (2006) Estrogen receptors and human disease. J Clin Invest 116:561\u2013570","journal-title":"J Clin Invest"},{"key":"580_CR8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1749-6632.2001.tb04039.x","volume":"949","author":"BS Komm","year":"2001","unstructured":"Komm BS, Lyttle CR (2001) Developing a SERM: stringent preclinical selection criteria leading to an acceptable candidate (WAY-140424) for clinical evaluation. Ann N Y Acad Sci 949:317\u2013326","journal-title":"Ann N Y Acad Sci"},{"key":"580_CR9","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1210\/en.2005-0030","volume":"146","author":"BS Komm","year":"2005","unstructured":"Komm BS, Kharode YP, Bodine PV, Harris HA, Miller CP, Lyttle CR (2005) Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity. Endocrinology 146:3999\u20134008","journal-title":"Endocrinology"},{"key":"580_CR10","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1021\/jm010086m","volume":"44","author":"CP Miller","year":"2001","unstructured":"Miller CP, Collini MD, Tran BD, Harris HA, Kharode YP, Marzolf JT, Moran RA, Henderson RA, Bender RH, Unwalla RJ, Greenberger LM, Yardley JP, Abou-Gharbia MA, Lyttle CR, Komm BS (2001) Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens. J Med Chem 44:1654\u20131657","journal-title":"J Med Chem"},{"key":"580_CR11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.111.072249","volume":"80","author":"JS Lewis-Wambi","year":"2011","unstructured":"Lewis-Wambi JS, Kim H, Curpan R, Grigg R, Sarker MA, Jordan VC (2011) The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor alpha and cyclin D1. Mol Pharmacol 80:610\u2013620","journal-title":"Mol Pharmacol"},{"key":"580_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ilar.45.2.212","volume":"45","author":"DF Archer","year":"2004","unstructured":"Archer DF (2004) Role of the nonhuman primate for research related to women\u2019s health. ILAR J 45:212\u2013219","journal-title":"ILAR J"},{"key":"580_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1095\/biolreprod.102.005215","volume":"68","author":"FL Bellino","year":"2003","unstructured":"Bellino FL, Wise PM (2003) Nonhuman primate models of menopause workshop. Biol Reprod 68:10\u201318","journal-title":"Biol Reprod"},{"key":"580_CR14","first-page":"307","volume":"1","author":"R Brommage","year":"2001","unstructured":"Brommage R (2001) Perspectives on using nonhuman primates to understand the etiology and treatment of postmenopausal osteoporosis. J Musculoskelet Neuronal Interact 1:307\u2013325","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"580_CR15","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ajp.20715","volume":"71","author":"SY Smith","year":"2009","unstructured":"Smith SY, Jolette J, Turner CH (2009) Skeletal health: primate model of postmenopausal osteoporosis. Am J Primatol 71:752\u2013765","journal-title":"Am J Primatol"},{"key":"580_CR16","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/01.AOG.0000163253.27610.b9","volume":"105","author":"S Ronkin","year":"2005","unstructured":"Ronkin S, Northington R, Baracat E, Nunes MG, Archer DF, Constantine G, Pickar JH (2005) Endometrial effects of bazedoxifene acetate, a novel selective estrogen receptor modulator, in postmenopausal women. Obstet Gynecol 105:1397\u20131404","journal-title":"Obstet Gynecol"},{"key":"580_CR17","unstructured":"Guidelines for preclinical and clinical evaluation of agents used in the prevention or treatment of postmenopausal osteoporosis. Division of Metabolic and Endocrine Drug Products; Food and Drug Administration. http:\/\/www.fda.gov . Accessed 28 Feb 2014"},{"key":"580_CR18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/8756-3282(93)90169-B","volume":"14","author":"K Lundon","year":"1993","unstructured":"Lundon K, Grynpas M (1993) The long-term effect of ovariectomy on the quality and quantity of cortical bone in the young cynomolgus monkey: a comparison of density fractionation and histomorphometric techniques. Bone 14:389\u2013395","journal-title":"Bone"},{"key":"580_CR19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","volume":"14","author":"CH Turner","year":"1993","unstructured":"Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595\u2013608","journal-title":"Bone"},{"key":"580_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"580_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S8756-3282(01)00465-3","volume":"29","author":"CE Hotchkiss","year":"2001","unstructured":"Hotchkiss CE, Stavisky R, Nowak J, Brommage R, Lees CJ, Kaplan J (2001) Levormeloxifene prevents increased bone turnover and vertebral bone loss following ovariectomy in cynomolgus monkeys. Bone 29:7\u201315","journal-title":"Bone"},{"key":"580_CR22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524\u2013531","journal-title":"Bone"},{"key":"580_CR23","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bone.2006.04.028","volume":"39","author":"MR Allen","year":"2006","unstructured":"Allen MR, Iwata K, Phipps R, Burr DB (2006) Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone 39:872\u2013879","journal-title":"Bone"},{"key":"580_CR24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/jbmr.2000.15.4.613","volume":"15","author":"T Mashiba","year":"2000","unstructured":"Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB (2000) Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 15:613\u2013620","journal-title":"J Bone Miner Res"},{"key":"580_CR25","doi-asserted-by":"crossref","unstructured":"Seeman E (2008) Structural basis of growth-related gain and age-related loss of bone strength. Rheumatology (Oxford) 47 Suppl 4:iv2\u2013iv8","DOI":"10.1093\/rheumatology\/ken177"},{"key":"580_CR26","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00198-008-0661-8","volume":"19","author":"EM Lewiecki","year":"2008","unstructured":"Lewiecki EM, Watts NB (2008) Assessing response to osteoporosis therapy. Osteoporos Int 19:1363\u20131368","journal-title":"Osteoporos Int"},{"key":"580_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00042192-200209000-00004","volume":"9","author":"CJ Lees","year":"2002","unstructured":"Lees CJ, Register TC, Turner CH, Wang T, Stancill M, Jerome CP (2002) Effects of raloxifene on bone density, biomarkers, and histomorphometric and biomechanical measures in ovariectomized cynomolgus monkeys. Menopause 9:320\u2013328","journal-title":"Menopause"},{"key":"580_CR28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","volume":"17","author":"SM Ott","year":"2002","unstructured":"Ott SM, Oleksik A, Lu Y, Harper K, Lips P (2002) Bone histomorphometric and biochemical marker results of a 2-year placebo-controlled trial of raloxifene in postmenopausal women. J Bone Miner Res 17:341\u2013348","journal-title":"J Bone Miner Res"},{"key":"580_CR29","first-page":"225","volume":"37","author":"JJ Stepan","year":"2003","unstructured":"Stepan JJ, Alenfeld F, Boivin G, Feyen JH, Lakatos P (2003) Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Endocr Regul 37:225\u2013238","journal-title":"Endocr Regul"},{"key":"580_CR30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-8529(02)00057-9","volume":"32","author":"A Fontana","year":"2003","unstructured":"Fontana A, Delmas PD (2003) Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis. Endocrinol Metab Clin North Am 32:219\u2013232","journal-title":"Endocrinol Metab Clin North Am"},{"key":"580_CR31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.bone.2006.05.007","volume":"39","author":"MR Allen","year":"2006","unstructured":"Allen MR, Iwata K, Sato M, Burr DB (2006) Raloxifene enhances vertebral mechanical properties independent of bone density. Bone 39:1130\u20131135","journal-title":"Bone"},{"key":"580_CR32","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/en.2007-0275","volume":"148","author":"MR Allen","year":"2007","unstructured":"Allen MR, Hogan HA, Hobbs WA, Koivuniemi AS, Koivuniemi MC, Burr DB (2007) Raloxifene enhances material-level mechanical properties of femoral cortical and trabecular bone. Endocrinology 148:3908\u20133913","journal-title":"Endocrinology"},{"key":"580_CR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01.gme.0000227858.50473.69","volume":"14","author":"C Lees","year":"2007","unstructured":"Lees C, Shen V, Brommage R (2007) Effects of lasofoxifene on bone in surgically postmenopausal cynomolgus monkeys. Menopause 14:97\u2013105","journal-title":"Menopause"},{"key":"580_CR34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.metabol.2008.03.012","volume":"57","author":"M Vrablik","year":"2008","unstructured":"Vrablik M, Fait T, Kovar J, Poledne R, Ceska R (2008) Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Metabolism 57:1088\u20131092","journal-title":"Metabolism"},{"key":"580_CR35","first-page":"721","volume":"83","author":"TB Clarkson","year":"1998","unstructured":"Clarkson TB, Anthony MS, Jerome CP (1998) Lack of effect of raloxifene on coronary artery atherosclerosis of postmenopausal monkeys. J Clin Endocrinol Metab 83:721\u2013726","journal-title":"J Clin Endocrinol Metab"},{"key":"580_CR36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2474-11-130","volume":"11","author":"C Christiansen","year":"2010","unstructured":"Christiansen C, Chesnut CH III, Adachi JD, Brown JP, Fernandes CE, Kung AW, Palacios S, Levine AB, Chines AA, Constantine GD (2010) Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskelet Disord 11:130","journal-title":"BMC Musculoskelet Disord"},{"key":"580_CR37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.maturitas.2010.05.009","volume":"67","author":"JH Pickar","year":"2010","unstructured":"Pickar JH, MacNeil T, Ohleth K (2010) SERMs: progress and future perspectives. Maturitas 67:129\u2013138","journal-title":"Maturitas"},{"key":"580_CR38","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/gme.0b013e3181c4f1d6","volume":"17","author":"JV Pinkerton","year":"2010","unstructured":"Pinkerton JV, Goldstein SR (2010) Endometrial safety: a key hurdle for selective estrogen receptor modulators in development. Menopause 17:642\u2013653","journal-title":"Menopause"},{"key":"580_CR39","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","volume":"281","author":"SR Cummings","year":"1999","unstructured":"Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC (1999) The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 281:2189\u20132197","journal-title":"JAMA"},{"key":"580_CR40","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/gme.0b013e3181a816be","volume":"16","author":"JV Pinkerton","year":"2009","unstructured":"Pinkerton JV, Archer DF, Utian WH, Menegoci JC, Levine AB, Chines AA, Constantine GD (2009) Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. Menopause 16:1102\u20131108","journal-title":"Menopause"},{"key":"580_CR41","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/gme.0b013e3181a818db","volume":"16","author":"DF Archer","year":"2009","unstructured":"Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD (2009) Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women. Menopause 16:1109\u20131115","journal-title":"Menopause"},{"key":"580_CR42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","volume":"23","author":"PD Miller","year":"2008","unstructured":"Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM, Woodson G, Levine AB, Constantine G, Delmas PD (2008) Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study. J Bone Miner Res 23:525\u2013535","journal-title":"J Bone Miner Res"},{"key":"580_CR43","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","volume":"23","author":"SL Silverman","year":"2008","unstructured":"Silverman SL, Christiansen C, Genant HK, Vukicevic S, Zanchetta JR, de Villiers TJ, Constantine GD, Chines AA (2008) Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. J Bone Miner Res 23:1923\u20131934","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0580-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-014-0580-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-014-0580-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:08:04Z","timestamp":1648609684000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-014-0580-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,16]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["580"],"URL":"https:\/\/doi.org\/10.1007\/s00774-014-0580-z","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,16]]}}}